SERVICE
Through Marker X's advanced and precise cancer screening services,
cancer will be easily detected.
01
AI Proteomics Early Cancer Screening
Check before any symptoms arise
Most early-stage cancers are difficult to detect. Cancer has been the leading cause of death among Taiwanese for 40 consecutive years. In Taiwan, on average, one person is diagnosed with cancer every five minutes. Through Marker X cancer screening services, cancer will no longer be able to hide.
Why Choose Marker X Biomedicine?
Choosing Marker X's cancer screening services ensures that you receive accurate and reliable test results, personalized health advice, privacy protection, and a convenient and fast testing process.We aim to help you gain deeper insights into your health condition and effectively maintain your well-being.
-
Fast｜Convenient and Swift
Our cancer screening services are extremely convenient and fast; only one blood sample is required, and results can be obtained within 10 working days. This not only saves time and money on transportation to and from hospitals but also significantly reduces the waiting time for test results.
-
Early｜Early Detection
Marker X's cancer screening can detect cancer at an early stage, including the earliest stage of in situ cancer and stage I cancer, making it an excellent tool for regular screening for high-risk populations. When cancer is detected early, the success rate of treatment is usually higher, and treatment duration can be shortened, reducing the cost of treatment.
-
Accurate｜ High Reliability
The target of Marker X's early multi-cancer screening is changes in proteins in the blood. Compared to genetic testing, this method can more accurately reflect the body's current condition. Additionally, compared to commonly used tumor markers, which use only a few proteins as indicators of disease presence, Marker X's multi-index analysis technology can significantly reduce the risk of misjudgment, improving the accuracy and reliability of the test.
-
Tailored｜Customized Reports
Each participant in the test will receive a customized cancer screening report. Our reports not only inform you of your current cancer risk but also provide comprehensive evaluations and personalized medical advice based on your lifestyle habits and dietary preferences. The content of the reports is supported by the latest medical research evidence, so you can confidently refer to and adjust your lifestyle and dietary habits accordingly.
-
Safe｜Privacy Protection
Marker X values your privacy; all test results and personal information are strictly kept confidential in compliance with regulations. We take appropriate security measures to ensure that your test data is not improperly disclosed without proper de-identification.
Marker X Early Multi-Cancer Screening Service
-
What cancer detection services does Marker X currently offer?
Currently, Marker X provides screening services for four types of cancer: colorectal cancer, esophageal cancer, breast cancer, and lung cancer. In the future, we will expand to include screening for gastric cancer, pancreatic cancer, and actively develop early screening indicators for cardiovascular diseases.
-
Does a high cancer risk index detected mean that cancer has already developed?
The cancer risk index reflects the current risk of cancer in the body. A higher value indicates a higher risk for cancer development. We recommend that you seek medical treatment promptly, and follow the physician's directives for further testing to confirm the diagnosis.
-
Who needs Marker X's early multi-cancer screening services?
Currently, the age of cancer patients are decreasing. Oftentimes, when our family and friends have been diagnosed with cancer, it is almost too late. Therefore, everyone over the age of 30 should undergo regular cancer screening to better understand their health conditions.It is highly recommended that people over the age of 50, especially those that are in a high-risk group (ex. family cancer history or stressful lifestyles) receive annual cancer screening tests to monitor their health.
-
If the current report values are all normal, how often should one undergo testing?
Because our lifestyle is dynamic, having normal values in the current report does not mean there is no risk of developing cancer in the future. Following the concept of preventive medicine, it is recommended that the general population undergo regular screening evaluations for cancer risk at least every 1-2 years to achieve the benefits of early detection and treatment.
FEATURE
-
Non-invasive
Only requires a standard blood draw,
No need for endoscopy or tissue biopsy -
Early Screening
Can predict risk as early as stage 0~I
Early detection, early interception of cancer development -
Screening for multiple types of cancer in one test
Convenient and effective
Just one blood draw
Can screen for multiple types of cancer -
Novel biomarkers and strategies
Exclusive technology
Analysis of plasma proteins
Interpreted using a multi-index algorithm
More accurate and sensitive
COMPARE
| Marker X Early Multi-Cancer Screening | Tumor Marker | Genetic Testing | Radiology (such as computed tomography, X-rays, etc.) |
|
|---|---|---|---|---|
| Analytical Targets | Cancer proteins in the blood | Tumor markers in the blood | Genes (DNA) in the blood cells | Radiological imaging as the primary diagnostic method |
| Early detection | Detect cancer risk including stage 0~1 | The false-negative rate for early-stage cancer is high. | Evaluating inherent cancer risk, rather than the current physical condition. | Relies on instrument sensitivity and the expertise of interpreting professionals. |
| Cancer screening accuracy | ||||
| Radiation risk | None | None | None | Radiological procedures such as Computed Tomography (CT) scans and X-rays pose radiation risks. |
| Invasive risks | Blood draw only | Blood draw only | Blood draw only | Endoscopic examinations are invasive, while painless tests carry risks associated with anesthesia. |
| Cost | Middle | Low | High | Middle~High |
| Overall Score |
ELIGIBLE PARTICIPANTS
- Age 35 and above
- Unhealthy habits or addictions (smoking, alcohol consumption, betel nut chewing)
- Experiencing high levels of work-related stress
- Family history of cancer
- Irregular lifestyle habits
- Health-conscious population
SERVICE PROCESS
-
STEP-1
Explanation of Testing Content
-
STEP-2
Collection of 3ml blood specimen
-
STEP-3
Delivery to the core laboratory
-
STEP-4
Receive test report within 10 working days.
-
STEP-5
Physician interpretation and consultation
SERVICE LOCATIONS
If you would like to further understand the content of Marker X Multi-Cancer Screening Service, please feel free to contact us using the Contact page.
02
Marker X Proteomics Analysis Service
Introduction
Proteomics is one of the most crucial research methods in the post-genomic era. Serving as the functional endpoints of organisms, protein analysis plays a significant role in biomedical research. Proteomic analysis based on high-resolution tandem mass spectrometry technology can be applied to basic research, clinical studies, and drug development. Consequently, proteomics has gained increasing attention worldwide. With the advancement of human genome sequencing projects and improvements in gene sequencing technology, a vast amount of information can be applied to proteomic research primarily using mass spectrometry instruments, further advancing life science research.
With years of experience in proteomic analysis, Marker X Biotech provides comprehensive technical services ranging from sample preparation, mass spectrometry analysis, protein identification, differential expression comparison, to bioinformatics analysis. Through customized experimental discussions, researchers can achieve efficient and professional analysis data, enhancing the quality of their research endeavors.
FEATURE
-
Utilizing High-Resolution Triple Quadrupole Mass Spectrometer
Using the Orbitrap triple quadrupole mass spectrometer as our analytical tool, we provide top-tier sensitivity and specificity analysis. The Orbitrap mass analyzer offers high-resolution and accurate mass (HRAM) performance advantages. When coupled with ultra-high-performance liquid chromatography equipment and its unique operational mode, it enhances protein identification and provides superior quantitative comparative information.
-
Offering Comprehensive Package Services
With years of service experience, Marker X understands users' needs and provides comprehensive package services. This allows researchers to focus more on their own research topics while Marker X delivers high-quality proteomic analysis services. The package includes customized sample pretreatment, high-resolution tandem mass spectrometry analysis, database matching of mass spectrometry data, differential protein expression analysis, and bioinformatics analysis of differential protein information (Gene Ontology annotation). A complete analysis report is provided after the service.
-
Method Development and Customized Sample Analysis Services
Marker X also offers customized method development services tailored to project requirements, devising analysis strategies, and providing comprehensive consulting services.
SERVICE ITEM
- Sample Handling and Preparation
- Protein Qualitative Analysis
- Protein Quantitative Analysis
- PTM (Post-Translational Modification) Protein Analysis
- Bioinformatics Analysis
- Comprehensive Proteomics Analysis Report
- Customized Methodology Research and Development Collaboration
Proteins in the samples are subjected to hydrolysis, followed by long-term high-resolution tandem mass spectrometry analysis to collect as much comprehensive proteomic information as possible. Subsequently, database matching, quantitative differential signal statistical analysis, Gene Ontology bioinformatics analysis, and other analyses are performed to provide a complete analysis report.
SERVICE PROCESS
Whole proteome project analysis (identity identification + differential comparison + biological function analysis)
Sample requirements
- Protein concentration ≥0.2 μg/μL, and processed to be non-infectious or radioactive.
- Volume ≥50 μL.
- Species of sample and solvent used for protein extraction must be specified.
- Marker X also offers sample homogenization procedures as an optional service.
Shipping specifications
- One set of original mass spectrometry data
- One final report and electronic file
Time required
Depending on individual project conditions, typically within 20 working days after sample acquisition.
-
STEP-1
Sample pre-processing
-
STEP-2
High-resolution tandem mass spectrometry analysis
-
STEP-3
Data interpretation and database comparison
-
STEP-4
Bioinformatics and differential analysis
-
OUTCOME
Whole proteome project analysis (identity identification + differential comparison + biological function analysis)
FAQ
-
Is there a limit to the number of samples that can be analyzed?
Marker X adopts a 'label-free quantification' strategy, which, under well-calibrated conditions, allows for an unlimited increase in the number of samples to be compared.
-
Can protein post-translational modifications be identified?
Yes, it is possible to analyze protein post-translational modifications by selecting them for analysis. Ruei-Chuan can analyze most of the post-translational modification types mentioned in the literature. For detailed experimental design, please consult with our specialists.
-
Can hormones or cell signaling molecules be identified?
Due to limitations of mass spectrometry instruments, if there is a significant difference in protein expression levels, signals from proteins expressed in small amounts (such as hormones or cell signaling molecules) may be obscured, making identification impossible. For detailed experimental design, please consult with our specialists.
-
Can all types of samples be analyzed?
Most biomedical research samples can be analyzed, except those containing infectious or radioactive substances. Specialized samples can also undergo protein identification as long as protein sequence information is available
Feel free to contact us for inquiries about our services and collaborations.
NEXT